Thomson Peter G. 4
4 · Fulcrum Therapeutics, Inc. · Filed Jan 25, 2021
Insider Transaction Report
Form 4
Thomson Peter G.
See Remarks
Transactions
- Sale
Common Stock
2021-01-21$14.00/sh−6,607$92,498→ 15,212 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2020.
- [F2]Includes 748 shares acquired under the Issuer's employee stock purchase plan on November 13, 2020.